Candriam SCA’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-167,221
| Closed | -$7.09M | – | 746 |
|
|
2023
Q4 | $7.09M | Sell |
167,221
-160,000
| -49% | -$6.78M | 0.05% | 300 |
|
|
2023
Q3 | $7.14M | Hold |
327,221
| – | – | 0.05% | 264 |
|
|
2023
Q2 | $10.4M | Hold |
327,221
| – | – | 0.08% | 241 |
|
|
2023
Q1 | $7.35M | Hold |
327,221
| – | – | 0.05% | 301 |
|
|
2022
Q4 | $10.3M | Sell |
327,221
-70,000
| -18% | -$2.21M | 0.07% | 272 |
|
|
2022
Q3 | $11.2M | Hold |
397,221
| – | – | 0.08% | 240 |
|
|
2022
Q2 | $10.5M | Buy |
397,221
+145,603
| +58% | +$3.85M | 0.09% | 217 |
|
|
2022
Q1 | $8.81M | Buy |
251,618
+146,019
| +138% | +$5.11M | 0.06% | 272 |
|
|
2021
Q4 | $3.42M | Buy |
+105,599
| New | +$3.42M | 0.02% | 439 |
|